Skip to main content

Advertisement

SpringerLink
Log in

Intra-articular injection of etanercept versus glucocorticoids in rheumatoid arthritis patients

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objectives

This study was conducted to assess the safety and efficacy of intra-articular injection of etanercept and compare it with corticosteroid injection in rheumatoid arthritis (RA) patients.

Methods

Fifty patients with RA who suffered from activity in one joint were randomized into two groups, received an intra-articular injection of either etanercept or corticosteroid guided by musculoskeletal ultrasound. All patients were assessed for disease activity by disease activity score (DAS28), functional assessment using the Modified Health Assessment Questionnaire (MHAQ), and laboratory investigations (erythrocyte sedimentation rate and C-reactive protein). Joints affected were evaluated for pain by visual analog scale (VAS), tenderness, and swelling scores and by ultrasound for estimation of synovial hypertrophy, synovial effusion, and power Doppler. Follow-up of the patients was done at weeks 1, 4, and 12 after injection by clinical assessment and ultrasound.

Results

There was a significant improvement of joint pain assessed by VAS, tenderness, and swelling scores in the etanercept group at week 1 and week 4 follow-up periods but there were insignificant changes at week 12. There was a significant decrease in synovial effusion at week 1 and week 4 and in power Doppler at week 1 but no significant change was noticed in synovial hypertrophy during the follow-up periods. In comparison of the two groups, etanercept has shown better results on joint scores at week 1; however, glucocorticoid had more sustained effects. No major or life-threatening side effects were noticed following intra-articular injection of etanercept.

Conclusion

Intra-articular injection of etanercept is a safe and promising option; with comparable results to intra-articular injection of corticosteroid; however, its rapid absorption from the synovium may necessitate frequent injections.

Key Points

• Persistent inflammatory mono-arthritis is a common clinical problem that is often difficult to treat; it is a debilitating and destructive condition.

• Intra-articular injection of TNF inhibitors is an encouraging treatment modality in managing refractory mono-arthritis in rheumatoid arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. McAllister K, Eyre S, Orozco G (2011) Genetics of rheumatoid arthritis: GWAS and beyond. Open Access Rheumatol 3:3–46

    Google Scholar 

  2. Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying anti-rheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960–977

    Article  Google Scholar 

  3. Schumacher HR, Chen LX (2005) Injectable corticosteroids in treatment of arthritis of the knee. Am J Med 118(11):1208–1214

    Article  CAS  Google Scholar 

  4. Fisher BA, Keat A (2006) Should we be using intra-articular tumor necrosis factor blockade in inflammatory mono-arthritis? J Rheumatol 33(10):1934–1935

    PubMed  Google Scholar 

  5. Carubbi F, Zugaro L, Cipriani P, Conchiglia A, Gregori L, Danniballe C, Letizia Pistoia M, Liakouli V, Ruscitti P, Ciccia F, Triolo G, Masciocchi C, Giacomelli R (2016) Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and mono-arthritis flare. Int J Immunopathol Pharmacol 29(2):252–266

    Article  CAS  Google Scholar 

  6. Monaco C, Nanchahal J, Taylor P, Feldmann M (2014) Anti-TNF therapy: past, present and future. Int Immunol 27(1):55–62

    Article  Google Scholar 

  7. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340(4):253–259

    Article  CAS  Google Scholar 

  8. Fiocco U, Sfriso P, Oliviero F, Lunardi F, Calabrese F, Scagliori E, Cozzi L, di Maggio A, Nardacchione R, Molena B, Felicetti M, Gazzola K, Stramare R, Rubaltelli L, Accordi B, Costa L, Roux-Lombard P, Punzi L, Dayer JM (2013) Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers. Joint Bone Spine 80(2):165–170

    Article  CAS  Google Scholar 

  9. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569–2581

    Article  Google Scholar 

  10. Prevoo ML, vańt Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48

    Article  CAS  Google Scholar 

  11. Pincus T, Summey JA, Soraci SA Jr et al (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26(11):1346–1353

    Article  CAS  Google Scholar 

  12. Ritchie DM, Boyle JA, McInnes JM et al (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37(147):393–406

    CAS  PubMed  Google Scholar 

  13. Carlsson AM (1983) Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16(1):87–101

    Article  Google Scholar 

  14. Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, Østergaard M (2003) Intero-bserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum 48(4):955–962

    Article  Google Scholar 

  15. Fiocco U, Ferro F, Vezzù M et al (2005) Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept. Ann Rheum Dis 64(6):899–905

    Article  CAS  Google Scholar 

  16. Lorenzo U, Fernando P (2012) Comprehensive SPSS program for estimating the tetrachoric correlation. Behav Res Methods 44(4):1191–1196

    Article  Google Scholar 

  17. Aalbers C, Gerlag D, Vos K, Vervoordeldonk M, Landewé R, Tak PP (2015) Intra-articular Etanercept treatment in inflammatory arthritis: a randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatment. Joint Bone Spine 82(5):338–344

    Article  CAS  Google Scholar 

  18. Zhang F, Ma C (2018) Comparison of the effectiveness on intra-articular and subcutaneous TNF inhibitor in rheumatoid arthritis patients. Clin Rheumatol 37(1):199–204

    Article  Google Scholar 

  19. Bliddal H, Terslev L, Qvistgaard E, Recke P, Holm CC, Danneskiold-Samsoe B, Savnik A, Torp-Pedersen S (2006) Safety of intra-articular injection of etanercept in small-joint arthritis: an uncontrolled, pilot-study with independent imaging assessment. Joint Bone Spine 73(6):714–717

    Article  CAS  Google Scholar 

  20. Haroon M, O’Gradaigh D (2010) Efficacy and safety of combining intra-articular methylprednisolone and anti-TNF agent to achieve prolonged remission in patients with recurrent inflammatory mono-arthritis. Joint Bone Spine 77(3):232–234

    Article  CAS  Google Scholar 

  21. Moelants EA, Mortier A, Van Damme J et al (2013) Regulation of TNF-α with a focus on rheumatoid arthritis. Immunol Cell Biol 91(6):393–401

    Article  CAS  Google Scholar 

  22. Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm CC, Rogind H, Boesen M, Danneskiold-Samsøe B, Torp-Pedersen S (2006) A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis. Scand J Rheumatol 35(5):341–345

    Article  CAS  Google Scholar 

  23. Boesen M, Boesen L, Jensen KE et al (2008) Clinical outcome and imaging changes after intra-articular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks. J Rheumatol 35(4):584–591

    CAS  PubMed  Google Scholar 

  24. Roux CH, Breuil V, Valerio L et al (2011) Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double blind, randomized pilot study. J Rheumatol 38(6):1009–1011

    Article  Google Scholar 

  25. MacMahon PJ, Eustace SJ, Kavanagh EC (2009) Injectable corticosteroid and local anesthetic preparations: a review for radiologists. Radiology 252(3):647–661

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Physical Medicine, Rheumatology, and Rehabilitation Department, Faculty of Medicine, Tanta University, Geish Street, Tanta, Gharbia, Egypt

    Rehab Mahmoud Salem, AE El-deeb, Mervat Elsergany, Hanan Elsaadany & Radwa El-khouly

Authors
  1. Rehab Mahmoud Salem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. AE El-deeb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mervat Elsergany
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hanan Elsaadany
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Radwa El-khouly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Radwa El-khouly.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salem, R.M., El-deeb, A., Elsergany, M. et al. Intra-articular injection of etanercept versus glucocorticoids in rheumatoid arthritis patients. Clin Rheumatol 40, 557–564 (2021). https://doi.org/10.1007/s10067-020-05235-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-020-05235-9

Keywords

Search

Navigation